Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Celsion Corp. | -0.780% | -2.290% | 17.431% | 0.787% | 115.126% | -90.725% | -95.325% |
India Globalization Capital | -13.930% | -7.895% | -7.080% | 51.079% | 60.305% | -65.058% | -56.058% |
Protara Therapeutics Inc. | 2.190% | -21.176% | -7.586% | -15.190% | 61.446% | -89.620% | - |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat